DCM
ITCI

Driehaus Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Driehaus Capital Management’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-369,617
Closed -$30.9M – 475
2024
Q4 		$30.9M Buy
369,617
+20,199
+6% +$1.66M 0.25% 125
2024
Q3 		$25.6M Buy
349,418
+133,979
+62% +$10.1M 0.22% 136
2024
Q2 		$14.8M Buy
+215,439
New +$14.9M 0.14% 183
2022
Q3 		– Sell
-514,956
Closed -$29.4M – 418
2022
Q2 		$29.4M Buy
514,956
+26,496
+5% +$1.5M 0.48% 54
2022
Q1 		$29.9M Buy
+488,460
New +$25.4M 0.37% 89
2021
Q3 		– Sell
-272,140
Closed -$11.1M – 499
2021
Q2 		$11.1M Buy
272,140
+55,185
+25% +$2.04M 0.15% 206
2021
Q1 		$7.36M Buy
216,955
+53,437
+33% +$1.85M 0.11% 239
2020
Q4 		$5.2M Buy
163,518
+63,874
+64% +$1.68M 0.08% 245
2020
Q3 		$2.56M Buy
+99,644
New +$2.27M 0.05% 249
2017
Q2 		– Sell
-17,964
Closed -$292K – 655
2017
Q1 		$292K Buy
+17,964
New +$260K 0.01% 479
2016
Q3 		– Sell
-93,536
Closed -$3.63M – 627
2016
Q2 		$3.63M Buy
93,536
+1,740
+2% +$62.5K 0.13% 169
2016
Q1 		$2.55M Sell
91,796
-11,351
-11% -$378K 0.08% 245
2015
Q4 		$5.55M Buy
103,147
+14,586
+16% +$736K 0.19% 121
2015
Q3 		$3.55M Buy
+88,561
New +$2.89M 0.13% 184

Other funds holding ITCI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Driehaus Capital Management's ITCI Position: Q1 2025 in Review

Driehaus Capital Management sold out of Intra-Cellular Therapies Inc. (ITCI) in Q1 2025, closing a stake of 369,617 shares — an estimated $30.9M sold.

Driehaus Capital Management first reported a position in ITCI in Q3 2015 and held it in 14 quarters. The position peaked at $30.9M in Q4 2024. 395 funds tracked by Wall St. Rank hold ITCI as of Q1 2025.

  • Driehaus Capital Management reported no remaining Intra-Cellular Therapies Inc. position as of Q1 2025 after selling out during the quarter.
  • Driehaus Capital Management sold 369,617 Intra-Cellular Therapies Inc. shares in Q1 2025, an estimated $30.9M.
  • Driehaus Capital Management first reported a position in Intra-Cellular Therapies Inc. in Q3 2015 and held it in 14 quarters.
  • Driehaus Capital Management's Intra-Cellular Therapies Inc. position peaked at $30.9M in Q4 2024.
  • 395 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q1 2025.

Based on Driehaus Capital Management's 13F filing for Q1 2025, filed 15 May 2025.